Proteomic analysis of bladder cancer cells reveals potential candidates of biomarkers in bladder tumorigenesis

Cancer Genomics and Proteomics

Volumn 2, Issue 3, 2005, Pages 151-157

  Wu, Ting Feng ^a   Wu, Hung ^a   Chow, Nan Hua ^b   Liao, Chin Feng ^b   Liu, Hsiao Sheng ^b,c  

^a SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Proteomics; Transitional cell carcinoma

Indexed keywords

CHAPERONIN CONTAINING T COMPLEX POLYPEPTIDE 1 BETA; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1 1; HEAT SHOCK PROTEIN 27; MASPIN; POLYPEPTIDE; PROHIBITIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CARCINOGENESIS; CANCER CELL CULTURE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; TANDEM MASS SPECTROMETRY; TRANSITIONAL CELL CARCINOMA; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 20344370976     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Chen CJ, Chuang YC, Lin TM and Wu HY: Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res 45: 5895-5899, 1985.
2. Catalona WJ: Urothelial tumors of the urinary tract. In: Campbell's Urology (Walsh PC, Retik AB, Stamey TA and Vaughn ED, eds). Philadelphia, W.B. Sanders, pp. 1094-1158, 1992.
3. Bane BL, Rao JY and Hemstreet GP: Pathology and staging of bladder cancer. Semin Oncol 23: 546-570, 1996.
4. Nseyo UO and Lamm DL: Therapy of superficial bladder cancer. Semin Oncol 23: 598-604, 1996.
5. Fujimoto K, Yamada Y, Okajima E, Kakizoe T, Sasaki H, Sugimura T and Terada M: Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res 52: 1393-1398, 1992.
6. Esrig D, Spruck CH 3rd, Nichols PW, Chaiwun B, Steven K, Groshen S, Chen SC, Skinner DG, Jones PA and Cote RJ: p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 143: 1389-1397, 1993.
7. Matsuyama H, Pan Y, Mahdy EA, Malmström P, Hedrum A, Uhlen M, Busch C, Hirano T, Auer G, Tribukait B, Naito K, Lichter P, Ekman P and Bergerheim USR: p53 deletion as a genetic marker in urothelial tumor by fluorescence in situ hybridization. Cancer Res 54: 6057-6060, 1994.
8. Serth J, Kuczyk MA, Bokemeyer C, Hervatin C, Nafe R, Tan HK and Johas U: p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. Br J Cancer 71: 201-205, 1995.
9. Ishikawa J, Xu HJ, Yandell DW, Maeda S and Kamidono S: Inactivation of the retinoblastoma gene in human bladder and renal cell carcinoma. Cancer Res 51: 5736-5743, 1991.
10. Presti JC, Reuter VE, Galan T, Fair WR and Cordon-Cordo C: Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 51: 5405-5409, 1991.
11. Chow NH, Liu HS and Chan SH: The role of nm23-H1 in the progression of transitional cell bladder cancer. Clin Cancer Res 6: 3595-3599, 2000.
12. Czerniak B, Cohen GL, Etkind P, Deith D, Simmons H, Herz F and Koss LG: Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas. Human Pathol 23: 1194-1204, 1992.
13. Knowles MA and Williamson M: Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing. Cancer Res 55: 133-139, 1993.
14. Saito S, Hata M, Fukuyama R, Sakai K, Kudoh J, Tazaki H and Shimizu N: Screening of H-ras gene point mutations in 50 cases of bladder carcinoma. Intl J Urol 4: 178-185, 1997.
15. Chow NH, Chan SH, Tzai TS, Ho CL and Liu HS: Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder. Clin Cancer Res 7: 1957-1962, 2001.
16. Yeh MY, Yu DS, Chen SC, Lin MS, Chang SY, Ma CP and Han SH: Establishment and characterization of a human urinary bladder carcinoma cell line (TSGH-8301). J Surg Oncol 37: 177-184, 1988.
17. Tzeng CC, Liu HS, Li C, Jin YT, Chen RM, Yang WH and Lin JS: Characterization of two urothelium cancer cell lines derived from a blackfoot disease endemic area in Taiwan. Anticancer Res 16: 1797-1804, 1996.
18. Yan JX, Wait R, Berkelman T, Harry RA, Westbrook JA, Wheeler CH and Dunn MJ: A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 21: 3666-3672, 2000.
19. Tsay YG, Wang YH, Chiu CM, Shen BJ and Lee SC: A strategy for identification and quantitation of phosphopeptides by liquid chromatography/tandem mass spectrometry. Anal Biochem 287: 55-64, 2000.
20. Davies BR, O'Donnell M, Durkan GC, Rudland PS, Barraclough R, Neal DE and Mellon JK: Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer. J Pathol 196: 292-299, 2002.
21. Seaton BA, Head JF, Kaetzel MA and Dedman JR: Purification, crystallization, and preliminary X-ray diffraction analysis of rat kidney annexin V, a calcium-dependent phospholipid-binding protein. J Biol Chem 265: 4567-4569, 1990.
22. Celis A, Rasmussen HH, Celis P, Basse B, Lauridsen JB, Ratz G, Hein B, Ostergaard M, Wolf H, Orntoft T and Celis JE: Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activities. Electrophoresis 20: 355-361, 1999.
23. Celis JE, Celis P, Palsdottir H, Ostergaard M, Gromov P, Primdahl H, Orntoft TF, Wolf H, Celis A and Gromova I: Proteomic strategies to reveal tumor heterogeneity among urothelial papillomas. Mol Cell Proteomics 1: 269-279, 2002
24. Orntoft TF, Thykjaer T, Waldman FM, Wolf H and Celis JE: Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas. Mol Cell Proteomics 1: 37-45, 2002.
25. Lebret T, Watson RW, Molinie V, O'Neill A, Gabriel C, Fitzpatrick JM and Botto H: Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma. Cancer 98: 970-977, 2003.
26. Ikonen E, Fiedler K, Parton RG and Simons K: Prohibitin, an antiproliferative protein, is localized to mitochondria. FEBS Lett 358: 273-277, 1995.
27. Byrjalsen I, Mose Larsen P, Fey SJ, Nilas L, Larsen MR and Christiansen C: Two-dimensional gel analysis of human endometrial proteins: characterization of proteins with increased expression in hyperplasia and adenocarcinoma. Mol Hum Reprod 5: 748-756, 1999.
28. Seow TK, Ong SE, Liang RC, Ren EC, Chan L, Ou K and Chung MC: Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry. Electrophoresis 21: 1787-1813, 2000.
29. Williams K, Chubb C, Huberman E and Giometti CS: Analysis of differential protein expression in normal and neoplastic human breast epithelial cell lines. Electrophoresis 19: 333-343, 1998.
30. Chen CJ, Chuang YC, Lin TM and Wu HY: Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res 45: 5895-5899, 1985.
31. Simeonova PP, Wang S, Toriuma W, Kommineni V, Matheson J, Unimye N, Kayama F, Harki D, Ding M, Vallyathan V and Luster MI: Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res 60: 3445-3453, 2000.
32. Liu J, Kadiiska MB, Liu Y, Lu T, Qu W and Waalkes MP: Stress-related gene expression in mice treated with inorganic arsenicals. Toxicol Sci 61: 314-320, 2001.
33. Reznikoff CA, Belair C, Savelieva E, Zhai Y, Pfeifer K, Yeager T, Thompson KJ, DeVries S, Bindley C and Newton MA: Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells. Genes Dev 8: 2227-2240, 1994.